Patients with inflammatory bowel disease at risk of sub-optimal outcomes report poorer biopsychosocial functioning than controls: data from two cross-sectional surveys

References

• Abdalla, M. I., Sandler, R. S., Kappelman, M. D., Martin, C. F., Chen, W., Anton, K., & Long, M. D. (2017). Prevalence and impact of inflammatory bowel disease–irritable bowel syndrome on patient-reported outcomes in CCFA partners. Inflammatory Bowel Diseases, 23(2), 325–331. doi:10.1097/MIB.0000000000001017
   PubMed Web of Science ®Google Scholar
• Bjelland, I., Dahl, A.A., Haug, T.T., & Neckelmann, D. (2002). The validity of the Hospital Anxiety and Depression Scale. An updated literature review. Journal of Psychosomatic Research, 52(2), 69–77. https://doi.org/10.1016/s0022-3999(01)00296-3
   PubMed Web of Science ®Google Scholar
• Brooks, A. J., Rowse, G., Ryder, A., Peach, E. J., Corfe, B. M., & Lobo, A. J. (2016). Systematic review: Psychological morbidity in young people with inflammatory bowel disease – Risk factors and impacts. Alimentary Pharmacology and Therapeutics, 44(1), 3–15. doi:10.1111/apt.13645
   PubMed Web of Science ®Google Scholar
• Brooks, A. J., Smith, P. J., & Lindsay, J. O. (2018). Monitoring adolescents and young people with inflammatory bowel disease during transition to adult healthcare. Frontline Gastroenterology, 9(1), 37–44. https://doi.org/10.1136/flgastro-2016-100747
   PubMed Web of Science ®Google Scholar
• Crohn’s & Colitis Australia. (2019). About Crohn’s & Colitis. https://www.crohnsandcolitis.com.au/about-crohns-colitis/
   Google Scholar
• Dober, M., Mikocka-Walus, A., Evans, S., Beswick, L., Emerson, C., & Olive, L. (2020). Perspectives on an acceptance and commitment therapy (ACT) based program for patients with inflammatory bowel disease and comorbid anxiety and/or depressive symptoms. Psychotherapy Research, 1–14. https://doi.org/10.1080/10503307.2020.1813915
   PubMed Web of Science ®Google Scholar
• Gracie, D. J., Guthrie, E. A., Hamlin, P. J., & Ford, A. C. (2018). Bi-directionality of brain–gut interactions in patients with inflammatory bowel disease. Gastroenterology, 154(6), 1635–1646.e3. doi:10.1053/j.gastro.2018.01.027
   PubMedGoogle Scholar
• Gracie, D. J., Williams, C. J. M., Sood, R., Mumtaz, S., Bholah, M. H., Hamlin, P. J., & Ford, A. C. (2017). Negative effects on psychological health and quality of life of genuine irritable bowel syndrome–type symptoms in patients with inflammatory bowel disease. Clinical Gastroenterology and Hepatology, 15(3), 376–384.e5. https://doi.org/10.1016/j.cgh.2016.05.012
   PubMed Web of Science ®Google Scholar
• Greuter, T., Manser, C., Pittet, V., Vavricka, S. R., & Biedermann, L. (2020). Gender differences in inflammatory bowel disease. Digestion, 101(Suppl1), 98–104. doi:10.1159/000504701
   PubMedGoogle Scholar
• Hvas, C. L., Bendix, M., Dige, A., Dahlerup, J. F., & Agnholt, J. (2018). Current, experimental, and future treatments in inflammatory bowel disease: A clinical review. Immunopharmacology and Immunotoxicology, 40(6), 446–460. doi:10.1080/08923973.2018.1469144
   PubMed Web of Science ®Google Scholar
• Iglesias-Rey, M., Barreiro-De Acosta, M., Caamaño-Isorna, F., Rodríguez, I. V., Ferreiro, R., Lindkvist, B., González, A. L., & Dominguez-Munoz, J. E. (2014). Psychological factors are associated with changes in the health-related quality of life in inflammatory bowel disease. Inflammatory Bowel Diseases, 20(1), 92–102. doi:10.1097/01.MIB.0000436955.78220.bc
   PubMed Web of Science ®Google Scholar
• Jackson, C. A., Clatworthy, J., Robinson, A., & Horne, R. (2010). Factors associated with non-adherence to oral medication for inflammatory bowel disease: A systematic review. American Journal of Gastroenterology, 105(3), 525–539. doi:10.1038/ajg.2009.685
   PubMed Web of Science ®Google Scholar
• Jäghult, S., Saboonchi, F., Johansson, U. B., Wredling, R., & Kapraali, M. (2011). Identifying predictors of low health-related quality of life among patients with inflammatory bowel disease: Comparison between Crohn’s disease and ulcerative colitis with disease duration. Journal of Clinical Nursing, 20(11–12), 1578–1587. doi:10.1111/j.1365-2702.2010.03614.x
   PubMed Web of Science ®Google Scholar
• Kingsley, M. J., & Abreu, M. T. (2016). A personalized approach to managing inflammatory bowel disease. Gastroenterology and Hepatology, 2(5), 308–315.
   Google Scholar
• Liu, J. J., Rosson, T. B., Xie, J. J., Harris, Z. P., McBride, R. G., Siegel, E., & Hagedorn, C. (2019). Personalized inflammatory bowel disease care reduced hospitalizations. Digestive Diseases and Sciences, 64(7), 1809–1814. doi:10.1007/s10620-019-05485-x
   PubMed Web of Science ®Google Scholar
• Lores, T., Goess, C., Mikocka-Walus, A., Collins, K. L., Burke, A. L. J., Chur-Hansen, A., Delfabbro, P., & Andrews, J. M. (2019). Integrated psychological care is needed, welcomed and effective in ambulatory inflammatory bowel disease management: evaluation of a new initiative. Journal of Crohn’s & Colitis, 13(7), 819–827. doi:10.1093/ecco-jcc/jjz026
   PubMed Web of Science ®Google Scholar
• Lores, T., Goess, C., Mikocka-Walus, A., Collins, K. L., Burke, A. L. J., Chur-Hansen, A., Delfabbro, P., & Andrews, J. M. (2021). Integrated Psychological Care Reduces Health Care Costs at a Hospital-Based Inflammatory Bowel Disease Service. Clinical Gastroenterology and Hepatology, 19(1), 96–103.e3. doi:10.1016/j.cgh.2020.01.030
   PubMed Web of Science ®Google Scholar
• Mikocka-Walus, A., Bampton, P., Hetzel, D., Hughes, P., Esterman, A., & Andrews, J. M. (2015). Cognitive-behavioural therapy has no effect on disease activity but improves quality of life in subgroups of patients with inflammatory bowel disease: A pilot randomised controlled trial. BMC Gastroenterology, 15(1), 1–13. doi:10.1186/s12876-015-0278-2
   PubMedGoogle Scholar
• Mikocka-Walus, A., Knowles, S. R., Keefer, L., & Graff, L. (2016). Controversies revisited: A systematic review of the comorbidity of depression and anxiety with inflammatory bowel diseases. Inflammatory Bowel Diseases, 22(3), 752–762. doi:10.1097/MIB.0000000000000620
   PubMed Web of Science ®Google Scholar
• Mikocka-Walus, A., Massuger, W., Knowles, S. R., Moore, G. T., Buckton, S., Connell, W., Pavli, P., Raven, L., & Andrews, J. M. (2020). Psychological distress is highly prevalent in inflammatory bowel disease: A survey of psychological needs and attitudes. JGH Open, 4(2), 166–171. doi:10.1002/jgh3.12236
   PubMed Web of Science ®Google Scholar
• Mikocka-Walus, A. A., Turnbull, D. A., Andrews, J. M., Moulding, N. T., & Holtmann, G. J. (2008). The effect of functional gastrointestinal disorders on psychological comorbidity and quality of life in patients with inflammatory bowel disease. Alimentary Pharmacology and Therapeutics, 28(4), 475–483. doi:10.1111/j.1365-2036.2008.03754.x
   PubMed Web of Science ®Google Scholar
• Nasiri, S., Kuenzig, M. E., & Benchimol, E. I. (2017). Long-term outcomes of pediatric inflammatory bowel disease. Seminars in Pediatric Surgery, 26(6), 398–404. doi:10.1053/j.sempedsurg.2017.10.010
   PubMed Web of Science ®Google Scholar
• Neuendorf, R., Harding, A., Stello, N., Hanes, D., & Wahbeh, H. (2016). Depression and anxiety in patients with inflammatory bowel disease: A systematic review. Journal of Psychosomatic Research, 87, 70–80. doi:10.1016/j.jpsychores.2016.06.001
   PubMed Web of Science ®Google Scholar
• Nurmi, E., Haapamäki, J., Paavilainen, E., Rantanen, A., Hillilä, M., & Arkkila, P. (2013). The burden of inflammatory bowel disease on health care utilization and quality of life. Scandinavian Journal of Gastroenterology, 48(1), 51–57. doi:10.3109/00365521.2012.685750
   PubMed Web of Science ®Google Scholar
• Sack, C., Phan, V. A., Grafton, R., Holtmann, G., Van Langenberg, D. R., Brett, K., Clark, M., & Andrews, J. M. (2012). A chronic care model significantly decreases costs and healthcare utilisation in patients with inflammatory bowel disease. Journal of Crohn’s and Colitis, 6(3), 302–310. doi:10.1016/j.crohns.2011.08.019
   PubMed Web of Science ®Google Scholar
• Sarid, O., Slonim-Nevo, V., Schwartz, D., Friger, M., Sergienko, R., Pereg, A., Vardi, H., Chernin, E., Singer, T., Greenberg, D., & Odes, S. (2018). Differing relationship of psycho-social variables with active ulcerative colitis or crohn’s disease. International Journal of Behavioral Medicine, 25(3), 341–350. doi:10.1007/s12529-018-9712-5
   PubMed Web of Science ®Google Scholar
• Sewell, J. L., & Velayos, F. S. (2013). Systematic review: The role of race and socioeconomic factors on IBD healthcare delivery and effectiveness. Inflammatory Bowel Diseases, 19(3), 627–643. doi:10.1002/ibd.22986
   PubMed Web of Science ®Google Scholar
• Zargar, A., Ahmadi Gooraji, S., Keshavarzi, B., & Haji Aghamohammadi, A. A. (2019). Effect of irritable bowel syndrome on sleep quality and quality of life of inflammatory bowel disease in clinical remission. International Journal of Preventive Medicine, 10(1), 10. doi:10.4103/ijpvm.IJPVM_364_17
   PubMedGoogle Scholar
• Zigmond, A. S., & Snaith, R. P. (1983). The Hospital Anxiety and Depression Scale. Acta Psychiatrica Scandinavica, 67(6), 361–370. doi:10.1111/j.1600-0447.1983.tb09716.x
   PubMed Web of Science ®Google Scholar